pI: 9.7514 |
Length (AA): 215 |
MW (Da): 23730 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
104 | 208 | 2e3j (A) | 117 | 234 | 34.00 | 0.57 | 0.11 | 0.410672 | 1.59 |
108 | 186 | 4me8 (A) | 55 | 165 | 37.00 | 0 | 0.99 | 0.482142 | -0.81 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Bradyzoite. | Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Oocyst. | Gregory Hehl AB Fritz HM |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_128814)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G23465 | peptidase-S24/S26 domain-containing protein |
Arabidopsis thaliana | AT1G53530 | peptidase-S24/S26 domain-containing protein |
Arabidopsis thaliana | AT1G29960 | peptidase-S24/S26 domain-containing protein |
Babesia bovis | BBOV_I004260 | conserved hypothetical protein |
Brugia malayi | Bm1_15285 | Peptidase S24-like domain containing protein |
Candida albicans | CaO19.3061 | Mitochondrial inner membrane protease |
Candida albicans | CaO19.10579 | Mitochondrial inner membrane protease |
Caenorhabditis elegans | CELE_C24H11.6 | Protein IMMP-1 |
Cryptosporidium hominis | Chro.40078 | hypothetical protein |
Cryptosporidium parvum | cgd4_620 | hypothetical protein |
Dictyostelium discoideum | DDB_G0283049 | hypothetical protein |
Drosophila melanogaster | Dmel_CG9240 | CG9240 gene product from transcript CG9240-RA |
Echinococcus granulosus | EgrG_001050600 | mitochondrial inner membrane protease subunit |
Echinococcus multilocularis | EmuJ_001050600 | mitochondrial inner membrane protease subunit |
Homo sapiens | ENSG00000148950 | IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
Loa Loa (eye worm) | LOAG_07003 | inner mitochondrial membrane protease family member |
Mus musculus | ENSMUSG00000042670 | IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
Neospora caninum | NCLIV_037440 | Mitochondrial inner membrane signal peptidase, related |
Oryza sativa | 4350939 | Os11g0620000 |
Plasmodium berghei | PBANKA_1418700 | microsomal signal peptidase, putative |
Plasmodium falciparum | PF3D7_1320400 | type I signal peptidase |
Plasmodium knowlesi | PKNH_1421000 | signal peptidase, putative |
Plasmodium vivax | PVX_122830 | big signal peptidase, putative |
Plasmodium yoelii | PY07139 | hypothetical protein |
Saccharomyces cerevisiae | YMR150C | Imp1p |
Schistosoma japonicum | Sjp_0058700 | ko:K09647 mitochondrial inner membrane protease subunit 1, putative |
Schistosoma mansoni | Smp_018430 | mitochondrial signal peptidase (S26 family) |
Schmidtea mediterranea | mk4.004706.02 | Mitochondrial inner membrane protease subunit 1 |
Toxoplasma gondii | TGME49_268910 | signal peptidase I protein |
Theileria parva | TP01_0970 | mitochondrial membrane protease subunit 2, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_268910 this record | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Staphylococcus aureus | Signal peptidase IB | 191 aa | 23.9% | 176 aa | Compounds | References |